Outcomes and Healthcare Resource Utilisation in Adults With von Willebrand Disease Receiving On‐Demand Recombinant von Willebrand Factor in the United Kingdom
Results support the effectiveness and safety profile of on-demand rVWF treatment for spontaneous/traumatic bleeds in adults with VWD, adding to the growing body of evidence for rVWF.
Authors
- Heena Howitt
- Anna Sanigorska (ORCID: https://orcid.org/0000-0001-7993-9501)
- Rosa Willock
- Michael Laffan (ORCID: https://orcid.org/0000-0002-8268-3268)
- Sarah Brighton (ORCID: https://orcid.org/0000-0003-3489-368X)
- Cheryl Jones (ORCID: https://orcid.org/0000-0002-4581-9496)
- Oliver Heard (ORCID: https://orcid.org/0009-0001-0087-3798)
Institutions
- Hammersmith Hospital (GB)
- Takeda (United Kingdom) (GB)
- Imperial College London (GB)
- London School of Economics and Political Science (GB)
Publication Details
- Journal
- European Journal Of Haematology
- Published
- 2025-10-10
- DOI
- https://doi.org/10.1111/ejh.70032
- Citations
- 2
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.54